2022 Study: U.S. Cannabis Laws Cost Pharmaceutical Firms Billions

Tue, Nov 28

Perspectives

U.S. Cannabis Laws Cost Pharmaceutical Firms Billions "The average change in a pharmaceutical company's market value for each state cannabis legalization event was $63 million, with an industry impact of $9.8 billion." #CannabisLaws #marijuana https://t.co/E3xxbeZAIB

704722

This article was featured in the Cannabis Commerce + Chemistry Podcast No. 10. Listen now. An August 2022 peer-reviewed research study entitled "U.S. Cannabis Laws Projected to Cost Generic and Brand...

Discover